The prognostic comparison of the patients with ≥ T2 or lymph node metastasis among the same three groups categorized according to the FSP1 and GPX4 expression revealed a pattern that was similar to that observed in the entire patient population (Fig. S1). The gene discussed is GPX4; the disease is metastatic malignant neoplasm in the lymph nodes.